Product Overview

Tigi Injection is a high-potency glycylcycline antibiotic containing Tigecycline. As the inaugural member of its class, Tigi was specifically developed to address the growing clinical challenge of multi-drug resistant (MDR) bacteria. It provides a broad spectrum of activity against both Gram-positive and Gram-negative pathogens, making it a critical "reserve" antibiotic for treating complicated infections in a hospital setting.

Pharmaceutical Classification

Tigi is a glycylcycline, a structural derivative of the tetracycline class. However, its unique molecular modification allows it to remain effective against bacteria that have developed common resistance mechanisms—such as efflux pumps and ribosomal protection—that render older antibiotics like minocycline or tetracycline ineffective.

Mechanism of Action

The active ingredient, Tigecycline, works by inhibiting bacterial protein synthesis. It binds to the 30S ribosomal subunit of the bacteria, preventing the entry of aminoacyl-tRNA into the A site of the ribosome. This action effectively halts the assembly of amino acids into proteins, preventing the bacteria from growing, replicating, or maintaining vital cellular functions.

Product Composition and Form

Tigi is supplied as a sterile, lyophilized (freeze-dried) powder for reconstitution and intravenous infusion.

Feature	Specification
Active Ingredient	Tigecycline
Common Strength	50 mg per vial
Drug Class	Glycylcycline Antibiotic
Primary Indication	Complicated Skin and Intra-abdominal Infections
Route	Intravenous (IV) Infusion

Pharmacokinetics and Tissue Distribution

Tigi is known for its exceptional volume of distribution, meaning it moves efficiently from the bloodstream into the body's tissues.

Rapid Distribution: After infusion, the drug rapidly moves into the skin, lungs, and abdominal tissues.
Metabolism: Tigecycline is not extensively metabolized by the liver, reducing the risk of certain drug-drug interactions.
Elimination: It is primarily excreted unchanged through the bile and feces, with a smaller portion eliminated via the kidneys.
Half-Life: It possesses a long terminal half-life (approximately 37 to 42 hours), allowing for twice-daily dosing.

Clinical Reliability and Spectrum

Tigi is utilized for its ability to target "superbugs" and complex infection sites.

MDR Coverage: Highly effective against MRSA (Methicillin-resistant Staphylococcus aureus), VRE (Vancomycin-resistant Enterococci), and many extended-spectrum beta-lactamase (ESBL) producing bacteria.
Complicated Skin Infections: Used for deep tissue infections, including diabetic foot infections and infected burns.
Intra-abdominal Infections: Targets complex polymicrobial infections such as peritonitis or complicated appendicitis.
Community-Acquired Bacterial Pneumonia (CABP): Effective against resistant strains of Streptococcus pneumoniae.

Precautions

Tigi Injection should be used with caution in certain individuals to ensure safe and effective treatment. Proper medical supervision is essential, especially in patients with underlying medical conditions or those receiving prolonged antibiotic therapy.

General Precautions

Use only under the supervision of a qualified healthcare professional
Complete the full prescribed course to prevent antibiotic resistance
Do not skip doses or stop treatment without medical advice
Avoid self-administration unless instructed by a healthcare provider

Liver Function Considerations

Tigecycline is processed by the liver
Use cautiously in patients with severe liver impairment
Dose adjustment may be required in certain liver conditions
Regular liver function monitoring may be recommended during extended treatment

Pregnancy & Breastfeeding

Not recommended during pregnancy unless clearly prescribed by a doctor
May affect fetal bone and tooth development
Use with caution during breastfeeding after consulting a healthcare professional
Discuss potential risks and benefits before use

Infection Monitoring Measures

Monitor for signs of allergic reactions during treatment
Report severe diarrhea, abdominal pain, or persistent nausea immediately
Regular medical evaluation may be required for prolonged therapy
Maintain proper hygiene and infection control practices to support recovery

Usage

General Usage Information

Tigi Injection (Tigecycline) is a broad-spectrum antibiotic used to treat serious bacterial infections by inhibiting bacterial protein synthesis and preventing the growth of infection-causing bacteria. Its effectiveness depends on correct dosage, proper administration, and completing the prescribed treatment course under medical supervision.

Key Usage Points

✔ Use only under the supervision of a qualified healthcare professional
✔ Administer exactly as prescribed, usually through intravenous infusion
✔ Complete the full course even if symptoms improve early
✔ Do not skip doses to avoid antibiotic resistance
✔ Inform your doctor about any allergies or liver-related conditions before use

Uses

Tigi Injection is commonly used in the treatment of serious bacterial infections, including complicated skin and soft tissue infections, intra-abdominal infections, and certain resistant bacterial infections when other antibiotics may not be suitable.

How to Use

Administer as an intravenous (IV) infusion by a healthcare professional
Usually given in a hospital or clinical setting
Dosage depends on the type and severity of infection, body condition, and medical response
Follow the prescribed treatment schedule carefully
Do not stop treatment without medical advice, even if symptoms improve early

Side Effects

General Safety Information

Tigi Injection (Tigecycline) is generally well tolerated when used as prescribed under medical supervision. Most side effects are mild to moderate and temporary, though their occurrence may vary depending on the patient’s health condition, infection severity, and treatment duration.

Common Side Effects

✔ Nausea or vomiting
✔ Diarrhea
✔ Abdominal pain or discomfort
✔ Headache
✔ Dizziness
✔ Injection site pain or irritation

These effects are usually temporary and often improve as the body adjusts to treatment.

Serious Side Effects (Rare but Important)

⚠ Seek medical attention if you experience:

Signs of severe allergic reaction (rash, itching, swelling, difficulty breathing)
Severe or persistent diarrhea (possible antibiotic-associated colitis)
Signs of liver problems (yellowing of skin/eyes, dark urine)
Severe abdominal pain (possible pancreatitis)
Unusual bleeding or bruising
Persistent weakness or worsening infection symptoms

Risk Factors & Monitoring

Higher risk in patients with liver disorders
Prolonged use may increase the risk of secondary infections
Liver function monitoring may be required during extended treatment
Close medical supervision is recommended in critically ill patients or those receiving multiple antibiotics

FAQs

What is Tigi Injection used for?
Tigi Injection is used to treat serious bacterial infections caused by susceptible bacteria. It is commonly prescribed for complicated skin infections, intra-abdominal infections, and certain resistant bacterial infections when other antibiotics may not be effective.

How does Tigi Injection work in the body?
It works by stopping the growth of bacteria. Tigecycline blocks bacterial protein synthesis, which prevents bacteria from multiplying and helps the body eliminate the infection.

Can Tigi Injection be given to children?
Tigi Injection is generally not recommended for children below 8 years of age unless specifically advised by a doctor, as it may affect bone and tooth development.

How is Tigi Injection administered?
It is given as an intravenous (IV) infusion by a qualified healthcare professional in a hospital or clinical setting. The dosage and duration depend on the type and severity of the infection.

What should I do if I miss a dose?
Since Tigi Injection is usually administered by a healthcare provider, missing a dose is unlikely. If a dose is missed, inform your doctor or healthcare provider immediately for further guidance.

Interactions

General Interaction Overview

Tigi Injection (Tigecycline) may interact with certain medications that can affect its therapeutic action or increase the risk of side effects. These interactions may alter drug effectiveness, increase bleeding risk, or require dose adjustments. It is important to inform your healthcare provider about all medicines, supplements, or herbal products you are currently using before starting treatment.

Commonly Reported Interactions

Blood thinners such as warfarin may increase the risk of bleeding and require close monitoring
Oral contraceptives (birth control pills) may have reduced effectiveness when used with antibiotics
Other antibiotics may sometimes alter treatment response when used together
Immunosuppressive medicines may require careful monitoring due to infection-related concerns
Drugs affecting liver function may influence how tigecycline is processed in the body
Anticoagulants or antiplatelet medicines may increase the chance of bleeding-related complications

Taking Tigi Injection under proper medical supervision helps minimize interaction risks and ensures safe, effective treatment. Always inform your doctor about all medications you are taking to avoid unwanted interactions and ensure the best therapeutic outcome.

More Information Demo
Manufacturer	:	Natco Pharma, India
Equivalent Brand	:	Tygacil
Generic Search	:	Tigecycline

Tigi Injection (Tigecycline)